Type I collagen, the major component of extracellular matrix in skin and other tissues, is a heterotrimer of two α1 and one α2 collagen polypeptides. The synthesis of both chains is highly regulated by different cytokines at the transcriptional level. Excessive synthesis and deposition of collagen in the dermal region causes thick and hard skin, a clinical manifestation of scleroderma. To better understand the causes of scleroderma or other tissue fibrosis, it is very Important to investigate the molecular mechanisms that cause upregulation of the Type I collagen synthesis in these tissues. Several cis-acting regulatory elements and trans-acting protein factors, which are involved in basal as well as cytokine-modulated Type I collagen gene expression, have been identified and characterized. Hypertranscription of Type I collagen in scleroderma skin fibroblasts may be due to abnormal activities of different positive or negative transcription factors In response to different abnormally induced signaling pathways. In this review, I discuss the present day understanding about the involvement of different factors in the regulation of basal as well as cytokine-modulated Type I collagen gene expression and its implication in scleroderma research.
RaghowR. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J8: 823–831, 1994.
2.
MyllyharjuJ, KivirikkoKI. Collagens and collagen-related diseases. Ann Med33: 7–21, 2001.
3.
ByersPH. Collagens: building blocks at the end of the development time. Clin Genet58: 270–279, 2000.
4.
UittoJ, ChuM-L. Regulation of collagen gene expression in human skin fibroblasts and its alterations in diseases. In: OlsenBR, NimniME, Eds. Collagen. Boca Raton, FL: CRC Press, pp 110–124, 1989.
5.
WidomRL. Regulation of matrix biosynthesis and degradation in systemic sclerosis. Curr Opin Rheumatol12: 534–539, 2000.
6.
UittoJ, KoubaD. Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J Dermatol Sci24: S60–S69, 2000.
7.
KahariVM, VuorioT, Nanto-SalonenK, VuorioE. Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. Biochem Biophys Acta781: 183–186, 1984.
8.
KahariVM, MultimakiP, VuorioE. Elevated pro-α2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene. FEBS Lett215: 331–314, 1987.
9.
TrojanowskaM, LeRoyEC, EckesB, KriegT. Pathogenesis of fibrosis: type I collagen and the skin. J Mol Med76: 266–274, 1998.
10.
RetiefE, ParkerMI, RetiefAE. Regional chromosome mapping of human collagen genes α2 (I) and αl (I) (COLIA2 and COLIA1). Hum Genet69: 304–308, 1985.
11.
ChuML, de WetW, BernardM, DingJF, MorabitoM, MyersJ, WilliamsC, RamirezF. Human pro-α1 (I) collagen gene structure reveals evolutionary conservation of a pattern of introns and exons. Nature310: 337–340, 1984.
12.
RamirezF, BernardM, ChuML, DicksonL, SangiorgiF, WeilD, de WetW, JunienC, SobelM. Isolation and characterization of the human fibrillar collagen genes. Ann N Y Acad Sci460: 117–129, 1985.
13.
de WetW, BernardM, Benson-ChandaV, ChuM-L, DicsonL, WellD, RamirezF. Organization of human pro-α (I) collagen gene. J Biol Chem262: 16032–16036, 1987.
14.
KarsentyG, de CrombruggheB. Conservation of binding sites for regulatory factors in the coordinately expressed α1(1) and α2 (I) collagen promoters. Biochem Biophys Res Commun177: 538–544, 1991.
15.
de WetWJ, ChuM-L, ProckopDJ. The mRNAs for the pro-αl(I) and pro-α2(I) chains of Type I procollagen are translated at the same rate in normal human fibroblasts and in fibroblasts from two variants of osteogenesis imperfecta with altered steady-state ratios of the two mRNAs. J Biol Chem258: 14385–14389, 1983.
16.
DalgleishR. The human type I collagen mutation database. Nucleic Acids Res25: 181–187, 1997.
17.
IhnH, OhnishiK, TamakiT, LeRoyEC, TrojanowskaM. Transcriptional regulation of human α2(I) collagen gene: combined action of upstream stimulatory and inhibitory cis-acting elements. J Biol Chem271: 26717–26723, 1996.
18.
GoldbergH, HelaakoskiT, GarrettLA, KarsentyG, PellegrinoA, LozanoG, MaityS, de CrombruggheB. Tissue-specific expression of the mouse α2(I) collagen promoter: studies in transgenic mice and in tissue culture cells. J Biol Chem267: 19622–19630, 1992.
19.
SimkevichCP, ThompsonJP, PoppletonH, RaghowR. The transcriptional tissue specificity of the human pro-αl (I) collagen gene is determined by a negative cis-regulatory element in the promoter. Biochem J286: 179–185, 1992.
20.
RossertJ, TerrazC, DupontS. Regulation of type I collagen genes expression. Nephrol Dial Transplant15: 66–68, 2000.
21.
RossouwCMS, VergeerWP, du PlooySJ, BernardMP, RamirezF, de WetWJ. DNA sequences in the first intron of the human pro-α1(1) collagen gene enhance transcription. J Biol Chem262: 15151–15157, 1987.
22.
SherwoodAL, BottenusRE, MartzenMR, BornsteinP. Structural and functional analysis of the first intron of the human α2(I) collagen-encoding gene. Gene89: 239–244, 1990.
23.
SherwoodAL, BornsteinP. Transcriptional control of the α1(1) collagen gene involves orientation- and position-specific intronic sequences. Biochem J265: 895–897, 1990.
24.
BornsteinP. Regulation of expression of α1 (I) collagen gene: a critical appraisal of the role of the first intron. Matrix Biol15: 3–10, 1996.
25.
KikuchiD, HaitiCW, SmithEA, LeRoyEC, TrojanowskaM. Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF-βl stimulation. Biochem Biophys Res Commun187: 45–50, 1992
26.
Shi-WenX, DentonCP, McWhirterA, Bou-GhariosG, AbrahamDJ, du BoisRM, BlackCM. Scleroderma lung fibroblasts exhibit elevated and dysregulated type I collagen biosynthesis. Arthritis Rheum40: 1237–1244, 1997.
27.
HitrayaEG, VargaJ, ArtlettCM, JimenezSA. Identification of elements in the promoter region of the α1(1) procollagen gene involved in its up-regulated expression in systemic sclerosis. Arthritis Rheum41: 2048–2058, 1998.
28.
HitrayaEG, JimenezSA. Transcriptional activation of the αl(I) procollagen gene in systemic sclerosis dermal fibroblasts: role of intronic sequences. Arthritis Rheum39: 1347–1354, 1996
29.
SenguptaPK, SmithBD. Methylation in the initiation region of the first exon suppresses collagen pro-α2(I) gene transcription. Biochem Biophys Acta1443: 75–89, 1998.
30.
SenguptaPK, EhrlichM, SmithBD. A methylation-responsive MDBP/RFX site is in the first exon of the collagen α2(I) promoter. J Biol Chem274: 36649–36655, 1999.
31.
ParkerMI, JudgeK, GeversW. Loss of type I procollagen gene expression in SV40-transformed human fibroblasts is accompanied by hypermethylation of these genes. Nucleic Acids Res10: 5879–5891, 1982.
32.
ParkerMI, GeversW. Demethylation of the type I procollagen genes in transformed fibroblasts treated with 5-azacytidine. Biochem Biophys Res Commun124: 236–243, 1984.
33.
RhodesK, BreindlM. Developmental changes in the methylation status of regulatory elements in the murine α1(1) collagen gene. Gene Exp2: 59–69, 1992.
34.
MaitySN, SinhaS, RuteshouserEC, de CrombruggheB. Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J Biol Chem267: 16574–16580, 1992.
35.
SinhaS, MaitySN, LuJ, de CrombruggheB. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc Natl Acad Sci U S A92: 1624–1628, 1995.
36.
CoustryF, MaitySN, SinhaS, de CrombruggheB. The transcriptional activity of the CCAAT-binding factor CBF is mediated by two distinct activation domains, one in the CBF-B subunit and the other in the CBF-C subunit. J Biol Chem271: 14485–14491, 1996.
37.
MaitySN, GolumbekPT, KarsentyG, de CrombruggheB. Selective activation of transcription by a novel CCAAT binding factor. Science241: 582–585, 1988.
38.
HuQ, MaitySN. Stable expression of a dominant negative mutant of CCAAT binding factor/NF-Y in mouse fibroblast cells resulting in retardation of cell growth and inhibition of transcription of various cellular genes. J Biol Chem275: 4435–4444, 2000.
39.
SaittaB, GaidarovaS, CicchillittiL, JimenezSA. CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. Arthritis Rheum43: 2219–2229, 2000.
40.
RossiP, KarsentyG, RobertsAB, RocheNS, SpornMB, de CrombruggheB. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β. Cell52: 405–414, 1988.
41.
KarsentyG, GolumbekP, de CrombruggheB. Point mutations and small substitution mutations in three different upstream elements inhibit the activity of the mouse α2(I) collagen promoter. J Biol Chem263: 13909–13915, 1988.
42.
KarsentyG, de CrombruggheB. Two diferent negative and one positive regulatory factors interact with a short promoter segment of the α1(I) collagen gene. J Biol Chem265: 9934–9942, 1990.
43.
RavazzoloR, KarsentyG, de CrombruggheB. A fibroblast-specific factor binds to an upstream negative control element in the promoter of the mouse αl(I) collagen gene. J Biol Chem266: 7382–7387, 1991.
44.
KarsentyG, RavazzoloR, de CrombruggheB. Purification and functional characterization of a DNA-binding protein that interacts with a negative element in the mouse α1(I) collagen promoter. J Biol Chem266: 24842–24848, 1991.
45.
HouglumK, BuckM, AdirV, ChojkierM. LAP (NF-IL6) transactivates the collagen αl(I) gene from a 5' regulatory region. J Clin Invest94: 808–814, 1994.
46.
AttardFA, WangL, PotterJJ, Rennie-TankersleyL, MezeyE. CCAAT/enhancer binding protein β mediates the activation of the murine αl(I) collagen promoter by acetaldehyde. Arch Biochem Biophys378: 57–64, 2000.
47.
GreenwelP, TanakaS, PenkovD, ZhangW, OliveM, MollJ, VinsonC, Di LibertoM, RamirezF. Tumor necrosis factor-α inhibits type I collagen synthesis through repressive CCAAT/enhancer-binding proteins. Mol Cell Biol20: 912–918, 2000.
48.
IraburuMJ, Dominguez-RosalesJA, FontanaL, AusterA, Garcia-TrevijanoER, Covarrubias-PinedoA, Rivas-EstillaAM, GreenwelP, RojkindM. Tumor necrosis factor-α down-regulates expression of the α1(1) collagen gene in rat hepatic stellate cells through a p20C/EBPβ- and C/EBPδ-dependent mechanism. Hepatology31: 1086–1093, 2000.
49.
TamakiT, OhnishiK, HartlC, LeRoyEC, TrojanowskaM. Characterization of a GC-rich region containing Spl binding site(s) as a constitutive responsive element of the α2(I) collagen gene in human fibroblasts. J Biol Chem270: 4299–4309, 1995.
50.
IhnH, TrojanowskaM. Sp3 is a transcriptional activator of the human α2(I) collagen gene. Nucleic Acids Res25: 3712–3717, 1997.
51.
Czuwara-LadykowskaJ, ShirasakiF, JackersP, WatsonDK, TrojanowskaM. Fli-1 inhibits collagen Type I production in dermal fibroblasts via an Spl-dependent pathway. J Biol Chem276: 20839–20848, 2001.
52.
ChenSJ, ArtlettCM, JimenezSA, VargaJ. Modulation of human α1(I) procollagen gene activity by interaction with Spl and Sp3 transcription factors in vitro. Gene215: 101–110, 1998.
53.
LiskaDJ, RobinsonVR, BornsteinP. Elements in the first intron of the α1(1) collagen gene interact with Spl to regulate gene expression. Gene Exp2: 379–389, 1992.
54.
NehlsMC, GrapilonML, BrennerDA. NFl/Spl switch elements regulate collagen αl(I) gene expression. DNA Cell Biol11: 443–452, 1992.
55.
RippeRA, AlmounajedG, BrennerDA. Spl binding activity increases in activated Ito cells. Hepatology22: 241–251, 1995.
56.
IhnH, TamakiK. Increased phosphorylation of transcription factor Spl in scleroderma fibroblasts: association with increased expression of type I collagen gene. Arthritis Rheum43: 2240–2247, 2000.
57.
VerrecchiaF, RossertJ, MauvielA. Blocking Spl transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis. J Invest Dermatol116: 755–763, 2001.
58.
LiskaDJ, SlackJL, BornsteinP. A highly conserved intronic sequence is involved in transcriptional regulation of the αl(I) collagen gene. Cell Regul1: 487–498, 1990.
59.
SlackJL, ParkerMI, RobinsonVR, BornsteinP. Regulation of collagen I gene expression by ras. Mol Cell Biol12: 4714–4723, 1992.
60.
SlackJL, ParkerMI, BornsteinP. Transcriptional repression of the αl(I) collagen gene by ras is mediated in part by an intronic AP1 site. J Cell Biochem58: 380–392, 1995.
61.
StuiverI, ShimizuY, ShimizuN. Phorbol ester-mediated expression of the collagen type I pro-α2 gene in mouse 3T3-L1 cells and its absence in a phorbol 12-myristate 13-acetate-nonresponsive variant. Biochem J278: 369–373, 1991.
62.
GoldsteinRH, FineA, FarnsworthLJ, PoliksC, PolgarP. Phorbol ester-induced inhibition of collagen accumulation by human lung fibroblasts. J Biol Chem265: 13623–13628, 1990.
63.
SilbigerS, LeiJ, NeugartenJ. Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1. Kidney Int55: 1268–1276, 1999.
64.
YakymovychI, ten DijkeP, HeldinCH, SouchelnytskyiS. Regulation of Smad signaling by protein kinase C. FASEB J15: 553–555, 2001.
65.
YuanLW, GambeeJE. Phosphorylation of p300 at serine 89 by protein kinase C. J Biol Chem275: 40946–40951, 2000.
66.
GhoshAK, YuanW, MoriY, VargaJ. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene19: 3546–3555, 2000.
67.
SiebenlistU, FranzosoG, BrownK. Structure, regulation and function of NF-κB. Annu Rev Cell Biol10: 405–455, 1994.
68.
KoubaDJ, ChungK-Y, NishiyamaT, VindevoghelL, KonA, KlementJF, UittoJ, MauvielA. Nuclear factor-κB mediates TNF-α inhibitory effect on α2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts. J Immunol162: 4226–4234, 1999.
69.
RippeRA, SchrumLW, StefanovicB, Solis-HerruzoJA, BrennerDA. NF-κB inhibits expression of the α1(I) collagen gene. DNA Cell Biol18: 751–761, 1999.
ChenSJ, YuanW, MoriY, LevensonA, TrojanowskaM, VargaJ. Stimulation of Type I collagen transcription in human skin fibroblasts by TGF-β: involvement of Smad3. J Invest Dermatol112: 49–57, 1999.
72.
PulaskiL, LandstromM, HeldinC-H, SouchelnytskyiS. Phosphorylation of Smad7 at Ser249 does not interfere with its inhibitory role in transforming growth factor-β-dependent signaling but affects Smad7-dependent transcriptional activation. J Biol Chem276: 14344–14349, 2001.
73.
VoN, GoodmanRH. CREB-binding protein and p300 in transcriptional regulation. J Biol Chem276: 13505–13508, 2001.
74.
ChanHM, La ThangueNB. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci114: 2363–2373, 2001.
75.
PiccininiG, LuchettiMM, CanigliaML, CarossinoAM, MontroniM, IntronaM, GabrielliA. c-myb proto-oncogene is expressed by quiescent scleroderma fibroblasts and, like B-myb gene, does not correlate with proliferation. J Invest Dermatol106: 1281–1286, 1996.
76.
FeghaliCA, BoulwareDW, FerrissJA, LevyLS. Expression of c-myc, c-myb, and c-sis in fibroblasts from affected and unaffected skin of patients with systemic sclerosis. Autoimmunity16: 167–171, 1993.
77.
PiccininiG, GolayJ, FloraA, SongiaS, LuchettiM, GabrielliA, IntronaM. C-myb, but not B-myb, upregulates Type I collagen gene expression in human fibroblasts. J Invest Dermatol112: 191–196, 1999.
78.
MarhamatiDJ, SonensheinGE. B-Myb expression in vascular smooth muscle cells occurs in a cell cycle-dependent fashion and down-regulates promoter activity of type I collagen genes. J Biol Chem271: 3359–3365, 1996.
79.
KypreosKE, NugentMA, SonensheinGE. Basic fibroblast growth factor-induced decrease in Type I collagen gene transcription is mediated by B-Myb. Cell Growth Differ9: 723–730, 1998.
80.
YangB-S, GeddesTJ, PogulisRJ, de CrombruggheB, FreytagSO. Transcriptional suppression of cellular gene expression by c-Myc. Mol Cell Biol11: 2291–2295, 1991.
81.
TrojanowskaM, WuLT, LeRoyEC. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts. Oncogene3: 477–481, 1988.
82.
GaleraP, MussoM, DucyP, KarsentyG. c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. Proc Natl Acad Sci U S A91: 9372–9376, 1994.
83.
WidomRL, CulicI, LeeJY, KornJH. Cloning and characterization of hcKrox, a transcriptional regulator of extracellular matrix gene expression. Gene198: 407–420, 1997.
84.
PeterkofskyB, GosiewskaA, SinghK, PearlmanS, MahmoodianF. Species differences in cis-acting elements of the pro α1(I) procollagen promoter and their binding proteins. J Cell Biochem73: 408–422, 1999.
85.
ImatakaH, SogawaK, YasumotoKI, KikuchiY, SasanoK, KobayashiA, HayamiM, Fujii-KuriyamaY. Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene. EMBO J11: 3663–3671, 1992.
86.
KobayashiA, SogawaK, ImatakaH, Fujii-KuriyamaY. Analysis of functional domains of a GC box-binding protein, BTEB. J Biochem117: 91–95, 1995.
87.
ChenA, DavisBH. UV irradiation activates JNK and increases αI(I) collagen gene expression in rat hepatic stellate cells. J Biol Chem274: 158–164, 1999.
88.
StrehlowD, JelaskaA, StrehlowK, KornJH. A potential role for protease nexin 1 overexpression in the pathogenesis of scleroderma. J Clin Invest103: 1179–1190, 1999.
89.
FeghaliCA, WrightTM. Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis. Arthritis Rheum42: 1451–1457, 1999.
90.
BergmanBL, ScottRW, BajpaiA, WattsS, BakerJB. Inhibition of tumor cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I. Proc Natl Acad Sci U S A83: 996–1000, 1986.
91.
WangQ, RaghowR. Okadaic acid-induced transcriptional downregulation of type I collagen gene expression is mediated by protein phosphatase 2A. Mol Cell Biochem158: 33–42, 1996.
92.
WestermarckJ, IlvonenE, KahariVM. The protein phosphatase inhibitor okadaic acid suppresses type I collagen gene expression in cultured fibroblasts at the transcriptional level. Biochem J308: 995–999, 1995.
93.
ReunanenN, FoschiM, HanJ, KahariVM. Activation of extracellular signal-regulated kinase 1/2 inhibits type I collagen expression by human skin fibroblasts. J Biol Chem275: 34634–34639, 2000.
94.
HayashidaT, PonceletAC, HubchakSC, SchnaperHW. TGF-β1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int56: 1710–1720, 1999.
95.
KernB, ShenJ, StarbuckM, KarsentyG. Cbfal contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem276: 7101–7107, 2001.
96.
AllistonT, ChoyL, DucyP, KarsentyG, DerynckR. TGF-β-induced repression of CBFA1 by Smad3 decreases cbfal and osteocalcin expression and inhibits osteoblasts differentiation. EMBO J20: 2254–2272, 2001.
97.
MoussadEE-DA, BrigstockDR. Connective tissue growth factor: what's in a name?Mol Genet Metabol71: 276–292, 2000.
98.
Shi-wenX, PenningtonD, HolmesA, LeaskA, BradhamD, BeauchampJR, FonsecaC, du BoisRM, MartinGR, BlackCM, AbrahamDJ. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res259: 213–224, 2000.
VargaJ, BasheyRI. Regulation of connective tissue synthesis in systemic sclerosis. Int Rev Immunol12: 187–199, 1995.
101.
BrantonMH, KoppJB. TGF-β and fibrosis. Microbes Infect1: 1349–1365, 1999.
102.
BlobeGC, SchiemannWP, LodishHF. Role of transforming growth factor-β in human diseases. N Engl J Med342: 1350–1358, 2000.
103.
RobertsAB. TGF-β signaling from receptors to the nucleus. Microbes Infect1: 1265–1273, 1999.
104.
ZhangY, DerynckR. Regulation of Smad signaling by protein associations and signaling crosstalk. Trends Cell Biol9: 274–279, 1999.
105.
MoriY, ChenSJ, VargaJ. Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-β. Exp Cell Res258: 374–383, 2000.
106.
ChenSJ, YuanW, LoS, TrojanowskaM, VargaJ. Interaction of Smad3 with a proximal Smad-binding element of the human α2(I) procollagen gene promoter required for transcriptional activation by TGF-β. J Cell Physiol183: 381–392, 2000.
107.
InagakiY, MamuraM, KanamaruY, GreenwelP, NemotoT, TakeharaK, ten DijkeP, NakaoA. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells. J Cell Physiol187: 117–123, 2001.
108.
GuoS, CichySB, HeX, YangQ, RaglandM, GhoshAK, JohnsonPF, UntermanTG. Insulin suppresses transactivation by CAAT/enhancer binding protein β (C/EBPβ)): signaling to p300/CREB binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPβ. J Biol Chem276: 8516–8523, 2001.
109.
ChungK-Y, AgarwalA, UittoJ, MauvielA. An AP-1 binding sequence is essential for regulation of the human α2(I) collagen (COL1A2) promoter activity by transforming growth factor-β. J Biol Chem271: 3272–3278, 1996.
110.
EngelME, McDonnellMA, LawBK, MosesHL. Interdependent SMAD and JNK signaling in transforming growth-β-mediated transcription. J Biol Chem274: 37413–37420, 1999.
111.
EickelbergO, PanskyA, KoehlerE, BihlM, TammM, HildebrandP, PerruchoudAP, KashgarianM, RothM. Molecular mechanisms of TGF-β antagonism by interferon-γ and cyclosporine A in lung fibroblasts. FASEB J15: 797–806, 2001.
112.
InagakiY, TruterS, RamirezF. Transforming growth factor-β stimulates α2(I) collagen gene expression through a cis-acting element that contains an Spl-binding site. J Biol Chem269: 14828–14834, 1994.
113.
GreenwelP, InagakiY, HuW, WalshM, RamirezF. Spl is required for the early response of α2(I)collagen to transforming growth factor-β1. J Biol Chem272: 19738–19745, 1997.
114.
ZhangW, QuJ, InagakiY, GreenwelP, RamirezF. Synergistic cooperation between Spl and Smad3/smad4 mediates transforming growth factor-βl stimulation of α2 (I)-collagen (COL1A2) transcription. J Biol Chem275: 39237–39245, 2000.
115.
InagakiY, NemotoT, NakaoA, ten DijkeP, KobayashiK, TakeharaK, GreenwelP. Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific α2(I) collagen gene transcription. J Biol Chem276: 16573–16579, 2001
116.
TsukazakiT, ChiangTA, DavidsonAF, AttisanoL, WranaJL. SARA, a FYVE domain protein that recruits Smad2 to the TGF-β receptor. Cell95: 779–791, 1998.
117.
GotoD, NakajimaH, MoriY, KurasawaK, KitamuraN, IwamotoI. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-β/Smad3-mediated signaling. Biochem Biophys Res Commun281: 1100–1105, 2001.
118.
WurthnerJU, FrankDB, FeliciA, GreenHM, CaoZ, SchneiderMD, McNallyJG, LechleiderRJ, RobertsAB. TGF-β receptor-associated protein 1 is a Smad4 chaperone. J Biol Chem276: 19495–19502, 2001.
119.
FranckA, BradshawAD, BassukJA, HoweCC, CouserWG, SageEH. SPARC regulates the expression of collagen Type I and transforming growth factor-β1 in mesangial cells. J Biol Chem274: 32145–32152, 1999.
120.
LeongGM, SubramaniamN, FigueroaJ, FlanaganJL, HaymanMJ, EismanJA, KouzmenkoAP. Ski-interacting protein (SKIP) interacts with Smad proteins to augment transforming growth factor-β-dependent transcription. J Biol Chem276: 18243–18248, 2001.
121.
NakaoA, AfrakhteM, MorenA, NakayamaT, ChristianJL, HeuchelR, ItohS, KawabataM, HeldinN-E, HeldinC-H, ten DijkeP. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signaling. Nature389: 549–551, 1997.
122.
HayashiH, AbdollahS, QiuY, CaiJ, XuYY, GrinnellBW, RichardsonMA, TopperJN, GimbroneMAJr., WranaJL, FalbD. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell89: 1165–1173, 1997.
PessahM, PrunierC, MaraisJ, FerrandN, MazarsA, LallemandF, GauthierJ-M, AtfiA. c-Jun interacts with the corepressor TG-interacting factor (TG1F) to suppress Smad2 transcriptional activity. Proc Natl Acad Sci U S A98: 6198–6203, 2001.
125.
EbisawaT, FukuchiM, MurakamiG, ChibaT, TanakaK, ImamuraT, MiyazonoK. Smurfl interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J Biol Chem276: 12477–12480, 2001.
126.
KavsakP, RasmussenRK, CausingCG, BonniS, ZhuH, ThomsenGH, WranaJL. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-β receptor for degradation. Mol Cell6: 1365–1375, 2000.
127.
DattaPK, MosesHL. STRAP and Smad7 synergize in the inhibition of transforming growth factor β signaling. Mol Cell Biol20: 3157–3167, 2000.
128.
KimRH, WangD, TsangM, MartinJ, HuffC, de CaesteckerMP, ParksWT, MengX, LechleiderRJ, WangT, RobertsAB. A novel Smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-β signal transduction. Genes Dev14: 1605–1616, 2000.
129.
KretzschmarM, DoodyJ, TimokhinaI, MassagueJ. A mechanism of repression of TGF-β/Smad signaling by oncogenic Ras. Genes Dev13: 804–816, 1999.
130.
StroscheinSL, WangW, ZhouS, ZhouQ, LuoK. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science286: 771–774, 1999.
131.
LuoK, StroscheinSL, WangW, ChenD, MartensE, ZhouS, ZhouQ. The Ski oncoprotein interacts with the Smad proteins to repress TGF-β signaling. Genes Dev13: 2196–2206, 1999.
132.
UlloaL, TabibzadehS. Lefty inhibits receptor-regulated Smad phosphorylation induced by the activated transforming growth factor-β receptor. J Biol Chem276: 21397–21404, 2001.
133.
WangT, DonahoePK, ZervosAS. Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science265: 674–676, 1994.
134.
WangT, LiBY, DanielsonPD, ShahPC, RockwellS, LechleiderRJ, MartinJ, ManganaroT, DonahoePK. The immunophilin FKBP12 functions as a common inhibitor of the TGF-β family type I receptors. Cell86: 435–444, 1996.
135.
OkadomeT, OedaE, SaitohM, IchijoH, MosesHL, MiyazonoK, KawabataM. Characterization of the interaction of FKBP12 with the transforming growth factor-β type I receptor in vivo. J Biol Chem271: 21687–21690, 1996.
136.
ChenRH, MiettinenPJ, MaruokaEM, ChoyL, DerynckR. A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature377: 548–552, 1995.
137.
ChoyL, DerynckR. The type II transforming growth factor (TGF)-β receptor-interacting protein TRIP-1 acts as a modulator of the TGF-β response. J Biol Chem273: 31455–31462, 1998.
138.
KahariVM, HeinoJ, VuorioE. Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. Biochem Biophys Acta929: 142–147, 1987.
139.
MauvielA, HeinoJ, KahariVM, HartmannDJ, LoyauG, PujolJP, VuorioE. Comparative effects of interleukin-1 and tumor necrosis factor-α on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol96: 243–249, 1991.
140.
JarischA, KriegT, HunzelmannN. Regulation of collagen expression by interleukin-1β is dependent on donor age. Acta Derm Venereol76: 287–290, 1996.
141.
GoldringMB, BirkheadJ, SandellLJ, KimuraT, KraneSM. Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest82: 2026–2037, 1988.
142.
RiquetFB, LaiWF, BirkheadJR, SuenLF, KarsentyG, GoldringMB. Suppression of Type I collagen gene expression by prostaglandins in fibroblasts is mediated at the transcriptional level. Mol Med6: 705–719, 2000.
143.
Armendariz-BorundaJ, KatayamaK, SeyerJM. Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1β, tumor necrosis factor-α, and transforming growth factor-β in Ito cells. J Biol Chem267: 14316–14321, 1992.
144.
DiazA, MunozE, JohnstonR, KornJH, JimenezSA. Regulation of human lung fibroblast alpha 1(I) procollagen gene expression by tumor necrosis factor-α, interleukin-1β and prostaglandin W2. J Biol Chem268: 10364–10371, 1993.
145.
PostlethwaiteAE, RaghowR, StricklinGP, PoppletonH, SeyerJM, KangAH. Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by hu man recombinant interleukin la and β. J Cell Biol106: 311–318, 1988.
146.
SchindlerC. Cytokines and JAK-STAT signaling. Exp Cell Res253: 7–14, 1999.
147.
VargaJ, OlsenA, HerhalJ, ConstantineG, RosenbloomJ, JimenezSA. Interferon-γ reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-β in normal fibroblasts. Eur J Clin Invest20: 487–493, 1990.
148.
KahariV-M, ChenYQ, SuMW, RamirezF, UittoJ. Tumor necrosis factor-α and interferon-γ suppress the activation of human Type I collagen gene expression by transforming growth factor-β. J Clin Invest86: 1489–1495, 1990.
149.
YufitT, ViningV, WangL, BrownRR, VargaJ. Inhibition of Type I collagen mRNA expression independent of tryptophan depletion in interferon-γ-treated human dermal fibroblasts. J Invest Dermatol105: 388–393, 1995.
150.
HigashiK, KoubaDJ, SongYJ, UittoJ, MauvielA. A proximal element within the human α2(I) collagen (COL1A2) promoter, distinct from the tumor necrosis factor-α response element, mediates transcriptional repression by interferon-γ. Matrix Biol16: 447–456, 1998.
151.
YuanW, YufitT, LiL, MoriY, ChenSJ, VargaJ. Negative modulation of α1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-γ. J Cell Physiol179: 97–108, 1999.
152.
GhoshAK, YuanW, MoriY, ChenSJ, VargaJ. Antagonistic regulation of type I collagen gene expression by interferon-γ and transforming growth factor-β: integration at the level of p300/CBP transcriptional coactivators. J Biol Chem276: 11041–11048, 2001.
153.
BaudV, KarinM. Signal transduction by tumor necrosis factor and its relatives. Trend Cell Biol11: 372–377, 2001.
154.
UllaoL, DoodyJ, MassagueJ. Inhibition of transforming growth factor-β/SMAD signaling by the interferon-γ/STAT pathway. Nature397: 710–713, 1999.
155.
VerrecchiaF, PessahM, AtfiA, MauvielA. Tumor necrosis factor-α inhibits transforming growth factor-3/Smad signaling in human dermal fibroblasts via AP-1 activation. J Biol Chem275: 30226–30231, 2000.
156.
BitzerM, von GersdorffG, LiangD, Dominguez-RosalesA, BegAA, RojkindM, BottingerEP. A mechanism of suppression of TGF-β/Smad signaling by NF-κB/RelA. Genes Dev14: 187–197, 2000.
